NTAGI To Review Covid Vaccine Data For Children In 5-12 Age Group
The NTAGI would review the Covid vaccine data for children in the age group of 5 to 12 years. This comes just days after the Drug Controller General of India (DCG) okayed Corbevax for children falling in the age bracket of 5 to 12 years, and Covaxin for children aged 6 to 12 years, for emergency use. The NTAGI recently also approved Covovax for children aged 12 to 17 years.